Company attributes
Location
B2X
0
Pitchbook URL
Number of Employees (Ranges)
1 – 10
Email Address
media@exavirtx.com0
Investors
Total Funding Amount (USD)
4,000,000
Latest Funding Type
Other attributes
Company Operating Status
Active
Exavir Therapeutics is a preclinical stage biotechnology company dedicated to eliminating HIV and other viral infections with a broad modality-agnostic approach, beginning with long-acting antiviral therapeutics.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.